Stock Quote

Nu Skin Enterprises, Inc (NUS) (NYSE Arca)
As of  2:46pm EST
27.16USD
Price Change
+1.16
Percent Change
+4.46%
 
$27.16
2:46pm EST
+4.46%
$26.00
$26.47
671,040
$27.41
$26.20
$27.10
$7.90
1.18
898,630

Research Another Stock: Symbol Look-up
UPDATE 1-Nu Skin raises Q4 outlook
Tuesday, 17 Nov 2009 08:32am EST 
RPT-FEATURE-Direct marketing gains new clout in Asia
Tuesday, 3 Nov 2009 07:00am EST 
UPDATE 1-Nu Skin Q3 profit meets Street view
Thursday, 29 Oct 2009 08:30am EDT 
REFILE-UPDATE 1-Nu Skin sees Q3 EPS ahead of Street
Tuesday, 20 Oct 2009 12:25pm EDT 
UPDATE 2-Nu Skin Q2 results top estimates, shares rise
Wednesday, 29 Jul 2009 03:08pm EDT 
37 Breakout Stocks on Big Volume, November 16, 2009
Tuesday, 17 Nov 2009 09:57am EST(Seeking Alpha) 
3 Stocks I Saw on TV
Wednesday, 11 Nov 2009 08:18am EST(The Street) 
23 Bullish Breakouts on Big Volume
Tuesday, 10 Nov 2009 05:57am EST(Seeking Alpha) 
Nu Skin Enterprises, Inc. Q3 2009 Earnings Call Transcript
Thursday, 29 Oct 2009 06:25pm EDT(Seeking Alpha) 
Kass: The Earnings Season Racket
Wednesday, 21 Oct 2009 01:00pm EDT(The Street) 
 
Name Current Position Compensation
Roney, Blake Executive Chairman of the Board 1,215,970
Hunt, M. Truman President, Chief Executive Officer, Director 1,934,020
Lund, Steven Vice Chairman of the Board 345,414

Profile

Nu Skin Enterprises, Inc. is a global direct selling company with operations in over 48 markets worldwide. The Company develops and distributes personal care products and nutritional supplements that are sold under the Nu Skin and Pharmanex brands. It conducts business using a direct selling model... Full Description

Company Address

Nu Skin Enterprises, Inc
75 West Center Street
Provo   UT   84601
P: +1801.3451000
F: +1801.3455999

Analyst Research

Performance of Key Competitors

Company Price Change
Avon Products, Inc. $35.22 +1.19
The Estee Lauder Companies Inc. $48.30 +0.44
The Estee Lauder Companies Inc. $0.00 0.00
  NUS Industry
P/E(TTM) 22.39 1.43
P/S(TTM) 1.28 0.14
ROI(TTM) 13.59 1.39
ROE(TTM) 22.50 3.77
Consensus Recommendation Outperform
EPS Est. (Current Period) 0.35
EPS Est. (Current Year) 1.44
Total Revenue $334.24M
Net Income $25.57M
EPS $0.40